Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR6833ApriorityCriticalpatent/CR6833A/en
Publication of CR6833ApublicationCriticalpatent/CR6833A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se refiere a metodos para tratar el crecimiento celular anormal en animales mamiferos administrando compuestos, a sales y solvatos o profarmacos farmaceuticamente aceptables de los mismos.It refers to methods for treating abnormal cell growth in mammalian animals by administering compounds, to pharmaceutically acceptable salts and solvates or prodrugs thereof.
CR6833A2002-11-272002-11-27
SUBSTITUTED BICYCLE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
CR6833A
(en)
USE OF TIADIAZOLO PYRIDINE DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MODULATED BY INHIBITION OF THE PHOSPHODIESTERASE (S)